HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.
Leader in Women’s Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Experience the cutting-edge Envision™ Mammography Platform (Graphic: ...
Hologic, Inc. HOLX is set to unveil groundbreaking technologies at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, to be held from Dec.
New data on Hologic’s (Nasdaq: HOLX) breast cancer detection technologies will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago ...
Breast cancer continues to be a significant global health challenge and the leading cause of cancer-related deaths among women. Artificial Intelligence is playing an increasingly vital role in ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...
Zacks Investment Research on MSN
Hologic trading near 52-week high: How should you play the stock?
Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...
Hologic HOLX will soon draw an end to its publicly traded phase, following an $18.3 billion agreement with U.S. private equity giants Blackstone and TPG. The buyout price consists of $76 per share in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback